Tuesday Nov 5, 2024
Maruti Cements Ad
Tuesday Nov 5, 2024

Roctavian

$2.9 million gene therapy for severe hemophilia

Jul 1, 2023
U.S. officials on Thursday approved drugmaker BioMarin’s gene therapy for the most common form of hemophilia.
Maruti Cements

Recent News

Nepalnews
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,


Newsroom
##

E-mail
nepalnewseditor@gmail.com

Social Media

Exploration

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal